secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2026-07-29T11:02:15+00:00
Accession:  0001860742-26-000086
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q2 revenue $1.394B (+9% YoY); raises FY2026 guidance
------------------------------------------------------------------

- Revenue $1.394B, up 9% reported and 8% constant currency YoY; GAAP net loss $14M vs $62M loss.
- Adjusted EBITDA $241M (+$50M YoY); Adjusted EBITDA ex-IPR&D $246M.
- Surgical revenue +19% (premium IOLs up 175%); Pharmaceuticals +15% (MIEBO/XIIDRA +27% H1).
- FY2026 revenue guidance raised to $5.44B-$5.54B; Adj. EBITDA ex-IPR&D raised to $1.025B-$1.075B.
- Cash flow from operations $153M, up from $35M; GAAP EPS ($0.04), adjusted EPS $0.15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074226000086/0001860742-26-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074226000086/blco-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001860742-26-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer